00:00Hello, I am Dr. Garima Joshi, from Sukhari University in Pharmacy Vibhaag.
00:05We have worked on the RUSA-2 project for oral delivery in treatment of cancer.
00:13My co-PI, Dr. Deepak Chaudhary, Pharmacy Vibhaag, and Dr. Harish Potney Vibhaag.
00:19Sheik Shainawaz Qadir was appointed as JRF.
00:22In this project, we have two drugs used for nanostructured lipid carriers.
00:29Gemsetwin Hydrochloride and Petlitexel, which are used in many kinds of cancer.
00:34We have worked on pancreatic cancer.
00:38We have made a patent for nanostructured lipid carriers, which has been granted by Indian patent.
00:45We have made a patent for nanostructured lipid carriers.
00:50We have also done animal studies, which have been received bioavailability enhancement after oral delivery.
00:56We have found nanostructured lipid carriers in Keco 2 cells,
01:00intestinal absorption barrier, absorption and uptake study,
01:06which has been obtained better than nanostructured lipid carriers.
01:10We have made a patent for nanostructured lipid carriers.
01:11We have also made a patent for pancreatic cells.
01:14After that, we have presented this work on the Grays University of Austria.
01:20We have also presented this work on the Grays University of Austria.
01:21We have also presented this work on the JRF.
01:25We have also made a travel grant from SRV.
01:26We have also made an extension of this RUSA work project.
01:28We have also made an extension for co-delivery of SIRNA with gemcitabine hydropuride nanostructured lipid carriers.
01:35We have also made an extension for JRF and Commonwealth Scholarship.
01:39We have also made a part of the PhD program in Liverpool John Murray University.
01:44Prof. Imran Salim has completed this work.
01:48In this project, we have made a better outcome for oral delivery.
01:53We have also made an extension for oral delivery.
01:55We have also made an extension for oral studies.
01:56We have also made an extension for oral studies.
